Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.93 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.79.
Market Cap
8.93T
Revenue
4.59T
Profits
199.3B
PE Ratio
44.79
Profit Margin
4.34%
Dividend Yield
0.40%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.07T | -2.48% | 2,433,468 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 611.34B | -1.76% | 7,615,093 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 444.17B | -1.14% | 4,408,975 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 377.13B | -1.08% | 5,502,959 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 317.20B | -0.73% | 7,830,903 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 290.16B | -0.70% | 2,544,109 | 60.44B |
| 7 | NVS | Novartis AG | 286.77B | -0.50% | 1,755,121 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 212.92B | -0.85% | 7,080,237 | 50.57B |
| 9 | AMGN | Amgen Inc. | 195.49B | 0.46% | 2,220,230 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 186.12B | -1.10% | 2,415,974 | 45.20B |
| 11 | ABT | Abbott Laboratories | 157.97B | -2.18% | 6,069,245 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 156.82B | -0.02% | 7,038,216 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 140.83B | -2.05% | 2,489,066 | 10.58B |
| 14 | PFE | Pfizer Inc. | 137.13B | -1.27% | 56,982,092 | 63.32B |
| 15 | DHR | Danaher Corporation | 134.71B | -1.27% | 3,452,633 | 24.78B |
| 16 | CVS | CVS Health Corporation | 132.19B | 0.02% | 5,515,092 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.06B | -0.60% | 1,653,615 | 12.22B |
| 18 | SYK | Stryker Corporation | 120.69B | -4.75% | 2,303,242 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.66B | -1.61% | 11,274,084 | 48.48B |
| 20 | GSK | GSK plc | 104.50B | -0.76% | 3,996,290 | 43.29B |
| 21 | SNY | Sanofi | 102.95B | -1.80% | 2,875,081 | 54.60B |
| 22 | MDT | Medtronic plc | 100.02B | -3.45% | 9,769,713 | 36.36B |
| 23 | MCK | McKesson Corporation | 88.62B | 1.26% | 1,297,501 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.51B | -0.61% | 1,226,730 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 84.02B | -0.29% | 1,510,797 | 200.42B |
| 26 | CI | The Cigna Group | 72.92B | -1.10% | 1,415,508 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 63.44B | -1.84% | 42,597,143 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.41B | -1.35% | 807,671 | 14.92B |
| 29 | ARGX | argenx SE | 55.78B | 1.76% | 343,453 | 4.74B |
| 30 | CAH | Cardinal Health, Inc. | 55.64B | 0.56% | 1,634,757 | 250.74B |
| 31 | COR | Cencora, Inc. | 55.08B | 0.52% | 1,542,808 | 328.68B |
| 32 | EW | Edwards Lifesciences Corporation | 52.09B | -0.78% | 3,567,022 | 6.30B |
| 33 | MDLN | Medline Inc. | 51.76B | -0.53% | 17,690,156 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.29B | 0.31% | 2,948,734 | 28.34B |
| 35 | HUM | Humana Inc. | 47.70B | 2.15% | 1,289,251 | 137.20B |
| 36 | BDX | Becton, Dickinson and Company | 41.68B | -2.53% | 2,047,262 | 22.23B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 41.51B | -1.81% | 761,825 | 4.45B |
| 38 | HLN | Haleon plc | 40.69B | -0.11% | 7,460,713 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.23B | 2.66% | 1,407,352 | 4.29B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.81B | -2.78% | 3,980,865 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 39.47B | 1.77% | 5,179,893 | 17.35B |
| 42 | NTRA | Natera, Inc. | 38.86B | -0.35% | 1,354,144 | 2.50B |
| 43 | A | Agilent Technologies, Inc. | 37.50B | -0.05% | 2,001,816 | 7.23B |
| 44 | WAT | Waters Corporation | 36.85B | 1.74% | 1,465,449 | 3.77B |
| 45 | ALC | Alcon Inc. | 32.96B | -0.75% | 1,969,092 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 32.29B | -1.79% | 2,488,306 | 2.44B |
| 47 | IQV | IQVIA Holdings Inc. | 32.25B | -0.03% | 1,347,582 | 16.63B |
| 48 | BIIB | Biogen Inc. | 31.89B | -0.28% | 1,026,756 | 9.94B |
| 49 | CNC | Centene Corporation | 31.70B | -0.54% | 2,980,879 | 178.33B |
| 50 | ONC | BeOne Medicines AG | 31.69B | -1.72% | 320,734 | 5.70B |
| 51 | ZTS | Zoetis Inc. | 30.13B | -1.90% | 5,448,115 | 9.53B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.13B | -1.55% | 3,432,355 | 20.98B |
| 53 | VEEV | Veeva Systems Inc. | 28.81B | 0.63% | 2,543,632 | 3.32B |
| 54 | RMD | ResMed Inc. | 28.15B | -1.76% | 1,242,564 | 5.54B |
| 55 | MRNA | Moderna, Inc. | 27.78B | 0.43% | 8,097,554 | 2.23B |
| 56 | ILMN | Illumina, Inc. | 26.64B | -2.76% | 1,723,628 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 25.98B | -3.77% | 4,277,903 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 25.84B | -0.06% | 1,090,496 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 25.81B | 1.48% | 197,682 | 4.09B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.45B | 1.90% | 6,146,754 | 8.26M |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.36B | 1.20% | 943,831 | 3.22B |
| 62 | BNTX | BioNTech SE | 23.52B | -1.33% | 558,718 | 3.23B |
| 63 | DGX | Quest Diagnostics Incorporated | 23.41B | -0.56% | 826,281 | 11.28B |
| 64 | INSM | Insmed Incorporated | 23.10B | 1.77% | 3,341,762 | 819.56M |
| 65 | UTHR | United Therapeutics Corporation | 22.99B | -0.59% | 505,851 | 3.17B |
| 66 | LH | Labcorp Holdings Inc. | 22.96B | 0.17% | 806,107 | 14.14B |
| 67 | INCY | Incyte Corporation | 22.65B | -1.13% | 1,677,778 | 5.36B |
| 68 | STE | STERIS plc | 20.52B | -1.28% | 829,551 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 19.90B | -2.39% | 3,235,811 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.50B | -2.13% | 10,246,165 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.94B | -0.92% | 1,056,995 | 3.10B |
| 72 | GMAB | Genmab A/S | 16.84B | 5.51% | 2,573,208 | 3.90B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 16.65B | -5.70% | 3,983,069 | 8.41B |
| 74 | ASND | Ascendis Pharma A/S | 16.59B | 1.31% | 505,585 | 998.25M |
| 75 | THC | Tenet Healthcare Corporation | 16.09B | -0.20% | 1,239,644 | 21.46B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.12B | 1.37% | 941,026 | 4.44B |
| 77 | MEDP | Medpace Holdings, Inc. | 15.12B | -1.00% | 321,191 | 2.68B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 14.59B | 3.47% | 3,237,522 | 579.96M |
| 79 | BTSG | BrightSpring Health Services, Inc. | 14.53B | 1.09% | 3,197,333 | 13.65B |
| 80 | DVA | DaVita Inc. | 14.30B | 1.36% | 798,145 | 13.84B |
| 81 | COO | The Cooper Companies, Inc. | 13.98B | 0.41% | 3,637,813 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.67B | 0.17% | 2,584,456 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.35B | -1.44% | 994,262 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 13.30B | 0.38% | 1,029,641 | 8.27B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 13.11B | -1.67% | 2,027,771 | 1.06B |
| 86 | SNN | Smith & Nephew plc | 12.85B | -4.89% | 3,803,678 | 6.16B |
| 87 | AXSM | Axsome Therapeutics, Inc. | 12.60B | 1.53% | 1,162,076 | 708.24M |
| 88 | PEN | Penumbra, Inc. | 12.42B | 0.09% | 352,362 | 1.45B |
| 89 | RVTY | Revvity, Inc. | 12.41B | 0.02% | 2,477,503 | 2.90B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 1.84% | 392,883 | 1.13B |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.30B | -0.46% | 3,458,990 | 4.89B |
| 92 | FMS | Fresenius Medical Care AG | 12.15B | -0.29% | 694,037 | 22.32B |
| 93 | ALGN | Align Technology, Inc. | 12.09B | -2.65% | 1,241,296 | 4.10B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.95B | -2.39% | 2,856,480 | 3.58B |
| 95 | MOH | Molina Healthcare, Inc. | 11.89B | -0.60% | 1,061,846 | 43.10B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.57B | -2.36% | 2,382,847 | 105.82M |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.49B | 1.29% | 2,707,382 | 622.01M |
| 98 | SMMT | Summit Therapeutics Inc. | 11.30B | 1.64% | 5,300,815 | - |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.06B | -0.75% | 1,669,564 | 3.24B |
| 100 | BAX | Baxter International Inc. | 11.01B | -3.18% | 6,789,757 | 11.32B |
| 101 | TECH | Bio-Techne Corporation | 11.00B | -0.40% | 15,448,852 | 1.21B |
| 102 | KRYS | Krystal Biotech, Inc. | 10.94B | -1.88% | 308,731 | 417.30M |
| 103 | CRL | Charles River Laboratories International, Inc. | 10.93B | 0.55% | 923,014 | 4.03B |
| 104 | GMED | Globus Medical, Inc. | 10.73B | -5.85% | 2,418,323 | 3.10B |
| 105 | PODD | Insulet Corporation | 10.55B | -3.44% | 1,050,022 | 2.90B |
| 106 | TEM | Tempus AI, Inc. | 10.40B | -0.70% | 4,764,239 | 1.36B |
| 107 | EHC | Encompass Health Corporation | 10.02B | 0.15% | 655,484 | 6.07B |
| 108 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.07% | 5,392,486 | - |
| 109 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 1,652,527 | - |
| 110 | HSIC | Henry Schein, Inc. | 9.51B | -0.93% | 1,179,245 | 13.38B |
| 111 | KYMR | Kymera Therapeutics, Inc. | 9.44B | 4.99% | 1,131,813 | 51.48M |
| 112 | CORT | Corcept Therapeutics Incorporated | 9.35B | -0.91% | 738,455 | 769.10M |
| 113 | PRAX | Praxis Precision Medicines, Inc. | 9.33B | -4.58% | 736,570 | 7.46M |
| 114 | ENSG | The Ensign Group, Inc. | 9.30B | 1.41% | 798,622 | 5.27B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 9.27B | 1.25% | 1,684,115 | 1.51B |
| 116 | IBRX | ImmunityBio, Inc. | 9.16B | -0.23% | 9,244,906 | 140.98M |
| 117 | BRKR | Bruker Corporation | 9.16B | 0.79% | 1,946,771 | 3.46B |
| 118 | UHS | Universal Health Services, Inc. | 9.00B | 1.15% | 931,946 | 17.76B |
| 119 | ALKS | Alkermes plc | 8.73B | -0.28% | 2,926,580 | 1.56B |
| 120 | OSCR | Oscar Health, Inc. | 8.60B | -3.02% | 6,789,329 | 13.30B |
| 121 | PCVX | Vaxcyte, Inc. | 8.39B | 0.66% | 2,462,180 | - |
| 122 | GKOS | Glaukos Corporation | 8.20B | -1.74% | 1,077,483 | 551.35M |
| 123 | QGEN | Qiagen N.V. | 8.09B | -1.71% | 2,476,791 | 2.10B |
| 124 | HIMS | Hims & Hers Health, Inc. | 8.02B | 3.83% | 13,157,579 | 2.37B |
| 125 | ATR | AptarGroup, Inc. | 7.99B | -0.07% | 328,595 | 3.87B |
| 126 | IMVT | Immunovant, Inc. | 7.91B | - | 1,382,919 | - |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 7.89B | 0.84% | 548,630 | 74.06M |
| 128 | BIO | Bio-Rad Laboratories, Inc. | 7.85B | -0.67% | 231,018 | 2.59B |
| 129 | TGTX | TG Therapeutics, Inc. | 7.79B | -1.40% | 2,562,589 | 700.35M |
| 130 | SYRE | Spyre Therapeutics, Inc. | 7.71B | -1.55% | 1,449,510 | - |
| 131 | RGEN | Repligen Corporation | 7.69B | -0.43% | 1,105,746 | 763.34M |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.61B | 0.91% | 980,173 | 217.17M |
| 133 | ABVX | ABIVAX Société Anonyme | 7.58B | 38.58% | 8,522,096 | 5.67M |
| 134 | HQY | HealthEquity, Inc. | 7.55B | 2.86% | 840,084 | 1.34B |
| 135 | LNTH | Lantheus Holdings, Inc. | 7.22B | 1.22% | 905,463 | 1.55B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.14B | -4.82% | 981,521 | 569.61M |
| 137 | LQDA | Liquidia Corporation | 7.09B | 6.19% | 1,674,509 | 288.07M |
| 138 | PTCT | PTC Therapeutics, Inc. | 6.76B | -0.02% | 2,061,889 | 827.11M |
| 139 | AVTR | Avantor, Inc. | 6.75B | -1.40% | 6,475,026 | 6.55B |
| 140 | PACS | PACS Group, Inc. | 6.75B | 6.74% | 1,450,356 | 5.43B |
| 141 | COGT | Cogent Biosciences, Inc. | 6.62B | -0.08% | 5,590,348 | - |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.59B | 0.07% | 1,674,717 | - |
| 143 | HNGE | Hinge Health, Inc. | 6.43B | 1.94% | 1,787,894 | 646.34M |
| 144 | TWST | Twist Bioscience Corporation | 6.42B | 4.74% | 1,900,229 | 409.48M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.34B | 0.66% | 769,249 | 274.48M |
| 146 | GRFS | Grifols, S.A. | 6.27B | -3.48% | 1,011,677 | 8.58B |
| 147 | CGON | CG Oncology, Inc. | 6.26B | -3.76% | 1,385,130 | 5.07M |
| 148 | DFTX | Definium Therapeutics, Inc. | 6.24B | 1.03% | 3,762,494 | - |
| 149 | CHE | Chemed Corporation | 6.16B | 1.37% | 198,469 | 2.54B |
| 150 | BLTE | Belite Bio, Inc | 6.06B | -0.46% | 225,066 | - |
| 151 | BLCO | Bausch + Lomb Corporation | 5.90B | -0.42% | 394,396 | 5.21B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.38% | 1,246,390 | 7.50M |
| 153 | ORKA | Oruka Therapeutics, Inc. | 5.74B | 2.98% | 1,569,655 | - |
| 154 | ERAS | Erasca, Inc. | 5.70B | 0.22% | 5,380,415 | - |
| 155 | TFX | Teleflex Incorporated | 5.63B | -0.19% | 355,239 | 2.13B |
| 156 | LEGN | Legend Biotech Corporation | 5.59B | -1.75% | 1,017,535 | 1.14B |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.52B | 0.06% | 2,212,084 | 3.05B |
| 158 | BLLN | BillionToOne, Inc. | 5.51B | -0.45% | 531,380 | 354.54M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.33B | 1.86% | 1,359,417 | 1.34M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.28B | -2.62% | 2,404,722 | 536.20M |
| 161 | CRSP | CRISPR Therapeutics AG | 5.26B | -3.16% | 1,173,721 | 4.10M |
| 162 | MANE | Veradermics, Incorporated | 5.13B | -0.63% | 606,836 | - |
| 163 | CELC | Celcuity Inc. | 5.11B | 2.13% | 1,084,087 | - |
| 164 | SHC | Sotera Health Company | 5.06B | 1.28% | 1,935,157 | 1.19B |
| 165 | CAI | Caris Life Sciences, Inc. | 5.03B | -2.92% | 3,615,201 | 907.29M |
| 166 | INDV | Indivior Pharmaceuticals, Inc. | 5.00B | -0.58% | 1,559,308 | 1.29B |
| 167 | STVN | Stevanato Group S.p.A. | 4.94B | 4.32% | 323,979 | 1.39B |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.93B | 2.43% | 3,247,431 | 4.26B |
| 169 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.92B | 2.44% | 1,303,945 | 754.05M |
| 170 | TXG | 10x Genomics, Inc. | 4.87B | 3.23% | 2,784,496 | 638.78M |
| 171 | RDNT | RadNet, Inc. | 4.85B | 4.07% | 791,273 | 2.14B |
| 172 | VCYT | Veracyte, Inc. | 4.69B | -2.43% | 1,322,358 | 541.74M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.53B | -1.32% | 3,078,813 | - |
| 174 | TNGX | Tango Therapeutics, Inc. | 4.52B | -3.96% | 4,760,663 | 56.99M |
| 175 | LIVN | LivaNova PLC | 4.52B | -0.96% | 663,551 | 1.43B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.37B | -0.76% | 968,009 | - |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.33B | 0.44% | 1,716,629 | 1.10B |
| 178 | NVST | Envista Holdings Corporation | 4.29B | -2.44% | 3,111,092 | 2.81B |
| 179 | MMED | MiniMed Group, Inc. | 4.20B | 0.54% | 843,969 | 3.10B |
| 180 | LFST | LifeStance Health Group, Inc. | 4.15B | 3.53% | 3,821,405 | 1.49B |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.13B | -1.16% | 470,333 | 1.54B |
| 182 | DNLI | Denali Therapeutics Inc. | 4.08B | -0.70% | 1,967,791 | - |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.08B | -5.19% | 5,795,730 | 10.68M |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 3.97B | 0.21% | 1,038,869 | 22.57M |
| 185 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.94B | 1.27% | 733,800 | 18.07M |
| 186 | WAY | Waystar Holding Corp. | 3.94B | 2.78% | 2,643,396 | 1.16B |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.91B | 0.54% | 491,535 | 787.85M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.89B | 2.12% | 182,672 | 803.79M |
| 189 | RCUS | Arcus Biosciences, Inc. | 3.88B | -0.77% | 1,328,694 | 236.00M |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.08% | 4,751,177 | 596.96M |
| 191 | BKD | Brookdale Senior Living Inc. | 3.84B | 1.45% | 4,003,446 | 3.00B |
| 192 | GPCR | Structure Therapeutics Inc. | 3.81B | 3.83% | 1,171,876 | - |
| 193 | CON | Concentra Group Holdings Parent, Inc. | 3.81B | 0.03% | 697,542 | 2.23B |
| 194 | DOCS | Doximity, Inc. | 3.79B | 0.58% | 3,211,464 | 644.86M |
| 195 | WRBY | Warby Parker Inc. | 3.72B | 0.75% | 2,468,297 | 890.57M |
| 196 | ICUI | ICU Medical, Inc. | 3.69B | -0.20% | 127,101 | 2.16B |
| 197 | DYN | Dyne Therapeutics, Inc. | 3.67B | 4.52% | 2,506,545 | - |
| 198 | ALMS | Alumis Inc. | 3.59B | 3.63% | 2,337,587 | 8.40M |
| 199 | OGN | Organon & Co. | 3.56B | - | 1,782,262 | 6.16B |
| 200 | ELVN | Enliven Therapeutics, Inc. | 3.54B | -0.18% | 1,982,131 | - |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | 1.97% | 1,586,843 | 225.27M |
| 202 | PBLS | Parabilis Medicines, Inc. | 3.49B | -6.24% | 579,473 | - |
| 203 | ADPT | Adaptive Biotechnologies Corporation | 3.43B | 0.23% | 3,783,945 | 295.41M |
| 204 | BEAM | Beam Therapeutics Inc. | 3.42B | -1.75% | 1,668,489 | 164.01M |
| 205 | HAE | Haemonetics Corporation | 3.41B | -0.16% | 553,886 | 1.33B |
| 206 | NHC | National HealthCare Corporation | 3.31B | 2.60% | 102,831 | 1.53B |
| 207 | OPCH | Option Care Health, Inc. | 3.29B | -1.59% | 2,206,839 | 5.67B |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -2.00% | 1,333,497 | 415.62M |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.28B | 8.82% | 6,681,028 | 670.00M |
| 210 | PRVA | Privia Health Group, Inc. | 3.24B | 0.59% | 863,374 | 2.25B |
| 211 | ITGR | Integer Holdings Corporation | 3.18B | 2.67% | 531,728 | 1.86B |
| 212 | QURE | uniQure N.V. | 3.17B | -2.85% | 2,046,339 | 18.09M |
| 213 | VERA | Vera Therapeutics, Inc. | 3.08B | -0.49% | 2,293,350 | - |
| 214 | RGC | Regencell Bioscience Holdings Limited | 3.06B | -0.32% | 434,306 | - |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.92B | -0.64% | 2,452,467 | 865.00K |
| 216 | GRAL | GRAIL, Inc. | 2.92B | -0.56% | 309,624 | 156.12M |
| 217 | KLRA | Kailera Therapeutics, Inc. | 2.84B | 1.27% | 853,110 | - |
| 218 | IRON | Disc Medicine, Inc. | 2.79B | -1.88% | 723,432 | - |
| 219 | CLOV | Clover Health Investments, Corp. | 2.75B | -1.60% | 4,206,514 | 2.21B |
| 220 | SLS | SELLAS Life Sciences Group, Inc. | 2.74B | -4.60% | 21,395,915 | - |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.71B | 6.61% | 3,244,763 | 3.37B |
| 222 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 2.68% | 1,119,291 | 535.08M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.70B | -0.56% | 677,964 | 776.83M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | 3.61% | 783,164 | 1.46B |
| 225 | TRVI | Trevi Therapeutics, Inc. | 2.65B | 0.05% | 3,086,047 | - |
| 226 | MBX | MBX Biosciences, Inc. | 2.63B | 2.41% | 1,056,977 | - |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.54B | 4.66% | 7,714,781 | 885.72M |
| 228 | ESTA | Establishment Labs Holdings Inc. | 2.53B | -1.53% | 609,524 | 229.58M |
| 229 | HTFL | HeartFlow, Inc. | 2.53B | -15.82% | 4,808,194 | 191.42M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.51B | 1.70% | 1,805,050 | 71.78M |
| 231 | AXGN | Axogen, Inc. | 2.46B | 3.38% | 1,201,018 | 238.11M |
| 232 | KOD | Kodiak Sciences Inc. | 2.43B | 3.31% | 1,548,124 | - |
| 233 | PHVS | Pharvaris N.V. | 2.40B | -0.86% | 1,020,054 | - |
| 234 | IMNM | Immunome, Inc. | 2.40B | 0.76% | 1,497,526 | 4.02M |
| 235 | ABCL | AbCellera Biologics Inc. | 2.39B | -3.45% | 7,716,574 | 79.21M |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 0.45% | 2,021,742 | - |
| 237 | NTLA | Intellia Therapeutics, Inc. | 2.36B | 1.87% | 3,781,848 | 66.09M |
| 238 | NKTR | Nektar Therapeutics | 2.36B | 6.74% | 1,717,992 | 55.63M |
| 239 | ASTH | Astrana Health, Inc. | 2.30B | 3.20% | 1,179,311 | 3.53B |
| 240 | TMDX | TransMedics Group, Inc. | 2.29B | -1.32% | 1,416,542 | 635.89M |
| 241 | VCEL | Vericel Corporation | 2.27B | -1.31% | 724,808 | 292.09M |
| 242 | PGNY | Progyny, Inc. | 2.26B | - | 1,239,804 | 1.29B |
| 243 | BHVN | Biohaven Ltd. | 2.24B | -0.27% | 3,174,269 | - |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | -1.50% | 726,183 | 1.09B |
| 245 | AGIO | Agios Pharmaceuticals, Inc. | 2.21B | -2.51% | 987,650 | 66.05M |
| 246 | BFLY | Butterfly Network, Inc. | 2.20B | -5.56% | 7,582,871 | 102.92M |
| 247 | PVLA | Palvella Therapeutics, Inc. | 2.20B | -0.87% | 462,692 | - |
| 248 | LMAT | LeMaitre Vascular, Inc. | 2.19B | -0.20% | 317,927 | 256.28M |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | 1.10% | 2,032,380 | 298.30M |
| 250 | TSHA | Taysha Gene Therapies, Inc. | 2.18B | 1.19% | 6,606,722 | 7.47M |
| 251 | SGRY | Surgery Partners, Inc. | 2.18B | 1.39% | 1,234,555 | 3.34B |
| 252 | GENB | Generate Biomedicines, Inc. | 2.17B | -0.12% | 1,322,719 | 30.30M |
| 253 | OCUL | Ocular Therapeutix, Inc. | 2.15B | -0.91% | 2,444,624 | 52.04M |
| 254 | ZLAB | Zai Lab Limited | 2.14B | 3.31% | 754,349 | 453.28M |
| 255 | XRAY | DENTSPLY SIRONA Inc. | 2.13B | -1.94% | 4,628,883 | 3.68B |
| 256 | KARD | Kardigan, Inc. | 2.11B | -8.76% | 807,682 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | 2.83% | 1,190,337 | 899.11M |
| 258 | UFPT | UFP Technologies, Inc. | 2.05B | 0.65% | 155,434 | 608.85M |
| 259 | SEM | Select Medical Holdings Corporation | 2.05B | -0.06% | 27,813,168 | 5.52B |
| 260 | GLUE | Monte Rosa Therapeutics, Inc. | 2.05B | 1.30% | 1,809,045 | 42.95M |
| 261 | WGS | GeneDx Holdings Corp. | 2.04B | -0.67% | 551,392 | 442.68M |
| 262 | STOK | Stoke Therapeutics, Inc. | 2.04B | 1.03% | 3,338,123 | 32.08M |
| 263 | PGEN | Precigen, Inc. | 2.03B | -3.80% | 4,110,192 | 31.60M |
| 264 | MD | Pediatrix Medical Group, Inc. | 2.03B | 2.53% | 704,039 | 1.93B |
| 265 | VRDN | Viridian Therapeutics, Inc. | 2.03B | -2.24% | 3,432,063 | 70.92M |
| 266 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.00B | -3.90% | 1,899,511 | -665.00K |
| 267 | RAPP | Rapport Therapeutics, Inc. | 2.00B | 3.34% | 556,047 | 20.00M |
| 268 | SION | Sionna Therapeutics, Inc. | 1.98B | 2.26% | 665,695 | - |
| 269 | NUVB | Nuvation Bio Inc. | 1.98B | 1.25% | 14,477,338 | 143.05M |
| 270 | ANAB | AnaptysBio, Inc. | 1.96B | 2.30% | 706,083 | 232.39M |
| 271 | ABSI | Absci Corporation | 1.96B | 2.11% | 5,799,449 | 1.84M |
| 272 | NEOG | Neogen Corporation | 1.95B | -1.37% | 2,328,638 | 870.56M |
| 273 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | -0.41% | 23,048,690 | 66.41M |
| 274 | BCAX | Bicara Therapeutics Inc. | 1.95B | 1.02% | 1,221,901 | - |
| 275 | ADMA | ADMA Biologics, Inc. | 1.94B | 0.12% | 2,779,735 | 509.86M |
| 276 | ATAI | AtaiBeckley Inc. | 1.94B | -1.68% | 7,028,849 | 3.49M |
| 277 | SNDX | Syndax Pharmaceuticals, Inc. | 1.94B | 0.28% | 2,474,019 | 217.17M |
| 278 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 0.94% | 162,503 | 1.20B |
| 279 | PLSE | Pulse Biosciences, Inc. | 1.92B | -5.20% | 291,441 | 751.00K |
| 280 | CMPS | COMPASS Pathways plc | 1.91B | -5.91% | 3,449,583 | - |
| 281 | ZYME | Zymeworks Inc. | 1.91B | 8.46% | 1,068,222 | 81.26M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.90B | 2.82% | 996,578 | 367.34M |
| 283 | TYRA | Tyra Biosciences, Inc. | 1.90B | -0.42% | 783,191 | - |
| 284 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | 5.70% | 4,212,350 | 2.18B |
| 285 | NEO | NeoGenomics, Inc. | 1.90B | 2.35% | 3,462,459 | 745.97M |
| 286 | TRLV | Trulieve Cannabis Corp. | 1.90B | 6.76% | 1,491,659 | 1.17B |
| 287 | OMCL | Omnicell, Inc. | 1.89B | 1.54% | 543,561 | 1.23B |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.88B | -2.38% | 212,740 | 87.16M |
| 289 | AVAH | Aveanna Healthcare Holdings Inc. | 1.87B | -1.04% | 1,635,511 | 2.52B |
| 290 | IOVA | Iovance Biotherapeutics, Inc. | 1.86B | -1.31% | 10,102,119 | 285.61M |
| 291 | GHRS | GH Research PLC | 1.85B | -5.19% | 212,575 | - |
| 292 | HCM | HUTCHMED (China) Limited | 1.85B | 1.12% | 101,521 | 548.51M |
| 293 | BHC | Bausch Health Companies Inc. | 1.84B | 1.55% | 3,641,322 | 10.53B |
| 294 | ADUS | Addus HomeCare Corporation | 1.84B | 2.50% | 295,534 | 1.45B |
| 295 | NBTX | Nanobiotix S.A. | 1.80B | 4.70% | 97,168 | 38.27M |
| 296 | URGN | UroGen Pharma Ltd. | 1.80B | 2.22% | 628,043 | 140.49M |
| 297 | AGL | agilon health, inc. | 1.79B | -6.70% | 469,597 | 5.82B |
| 298 | AKTS | Aktis Oncology, Inc. | 1.78B | 7.24% | 711,080 | 8.28M |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | -1.58% | 231,741 | 923.71M |
| 300 | COAG | Hemab Therapeutics Holdings, Inc. | 1.75B | 2.23% | 321,546 | - |
| 301 | NVCR | NovoCure Limited | 1.75B | -2.23% | 1,410,578 | 674.41M |
| 302 | MESO | Mesoblast Limited | 1.75B | -0.37% | 113,818 | 65.38M |
| 303 | VIR | Vir Biotechnology, Inc. | 1.72B | -1.83% | 1,719,564 | 65.50M |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.69B | 0.65% | 559,171 | 1.85B |
| 305 | INVA | Innoviva, Inc. | 1.68B | -1.84% | 609,887 | 420.69M |
| 306 | MAZE | Maze Therapeutics, Inc. | 1.65B | 2.93% | 650,508 | 20.00M |
| 307 | FTRE | Fortrea Holdings Inc. | 1.65B | -0.63% | 1,080,942 | 2.71B |
| 308 | MPLT | MapLight Therapeutics, Inc. | 1.63B | 4.68% | 418,192 | - |
| 309 | AVBP | ArriVent BioPharma, Inc. | 1.62B | 1.06% | 643,799 | - |
| 310 | IMCR | Immunocore Holdings plc | 1.61B | 4.34% | 604,358 | 412.81M |
| 311 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | -2.19% | 3,614,101 | 204.73M |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.61B | -2.31% | 1,433,688 | - |
| 313 | INNV | InnovAge Holding Corp. | 1.61B | 1.89% | 920,857 | 949.17M |
| 314 | ZBIO | Zenas BioPharma, Inc. | 1.60B | -0.74% | 865,873 | 10.00M |
| 315 | DMRA | Damora Therapeutics, Inc. | 1.60B | 7.35% | 569,212 | - |
| 316 | HROW | Harrow, Inc. | 1.58B | 3.28% | 1,062,857 | 268.68M |
| 317 | SVRA | Savara Inc. | 1.57B | 2.40% | 2,136,794 | - |
| 318 | AAPG | Ascentage Pharma Group International | 1.56B | -1.75% | 458 | 82.08M |
| 319 | NVAX | Novavax, Inc. | 1.55B | 0.64% | 3,943,179 | 596.34M |
| 320 | TDOC | Teladoc Health, Inc. | 1.53B | -2.36% | 3,605,051 | 2.51B |
| 321 | SEPN | Septerna, Inc. | 1.51B | -3.60% | 747,220 | 72.26M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | 0.28% | 313,823 | 83.72M |
| 323 | CDNA | CareDx, Inc. | 1.47B | -2.78% | 642,648 | 412.82M |
| 324 | AVLN | Avalyn Pharma Inc. | 1.46B | 6.16% | 531,447 | - |
| 325 | PRGO | Perrigo Company plc | 1.44B | 3.43% | 3,921,794 | 4.18B |
| 326 | STAA | STAAR Surgical Company | 1.43B | -2.18% | 646,621 | 290.38M |
| 327 | ATRC | AtriCure, Inc. | 1.42B | -2.54% | 1,198,132 | 552.16M |
| 328 | ARDT | Ardent Health, Inc. | 1.41B | -0.60% | 279,285 | 6.43B |
| 329 | PSNL | Personalis, Inc. | 1.40B | -2.73% | 3,366,755 | 64.52M |
| 330 | IART | Integra LifeSciences Holdings Corporation | 1.40B | -4.22% | 927,035 | 1.64B |
| 331 | CAPR | Capricor Therapeutics, Inc. | 1.39B | 1.18% | 1,856,139 | 11.13M |
| 332 | AHCO | AdaptHealth Corp. | 1.39B | 2.01% | 1,570,003 | 3.29B |
| 333 | INBX | Inhibrx Biosciences, Inc. | 1.38B | -1.18% | 190,575 | 1.30M |
| 334 | IMTX | Immatics N.V. | 1.38B | 5.91% | 732,902 | 43.00M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.38B | -0.19% | 1,248,559 | 101.66M |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.37B | 2.39% | 2,193,942 | 314.85M |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.33B | -9.00% | 3,958,988 | 787.08M |
| 338 | MNKD | MannKind Corporation | 1.32B | 0.71% | 6,536,626 | 360.78M |
| 339 | JBIO | Jade Biosciences, Inc. | 1.32B | 0.43% | 892,805 | - |
| 340 | OMDA | Omada Health, Inc. | 1.30B | 1.27% | 851,280 | 283.30M |
| 341 | PNTG | The Pennant Group, Inc. | 1.29B | 1.87% | 315,452 | 1.02B |
| 342 | INSP | Inspire Medical Systems, Inc. | 1.29B | -0.65% | 647,740 | 915.25M |
| 343 | PRCT | PROCEPT BioRobotics Corporation | 1.29B | - | 1,302,618 | 322.02M |
| 344 | PAHC | Phibro Animal Health Corporation | 1.27B | -1.38% | 295,245 | 1.50B |
| 345 | ARDX | Ardelyx, Inc. | 1.26B | -2.39% | 7,351,904 | 427.68M |
| 346 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 3.42% | 1,489,363 | - |
| 347 | AMN | AMN Healthcare Services, Inc. | 1.25B | -0.09% | 827,511 | 3.42B |
| 348 | MGTX | MeiraGTx Holdings plc | 1.25B | 7.74% | 1,766,008 | 79.76M |
| 349 | ALVO | Alvotech | 1.25B | -0.94% | 853,796 | 562.04M |
| 350 | SDGR | Schrödinger, Inc. | 1.22B | -6.38% | 2,667,527 | 254.91M |
| 351 | IRMD | IRADIMED CORPORATION | 1.21B | 1.01% | 81,466 | 86.28M |
| 352 | EYPT | EyePoint, Inc. | 1.20B | 1.24% | 2,314,491 | 7.61M |
| 353 | XNCR | Xencor, Inc. | 1.20B | 3.37% | 1,495,862 | 97.36M |
| 354 | QDEL | QuidelOrtho Corporation | 1.19B | -3.95% | 1,657,371 | 2.66B |
| 355 | ENOV | Enovis Corporation | 1.19B | -6.13% | 2,373,281 | 2.28B |
| 356 | AZTA | Azenta, Inc. | 1.18B | 0.08% | 379,658 | 596.48M |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | 0.68% | 343,061 | 796.33M |
| 358 | NUTX | Nutex Health Inc. | 1.17B | 1.43% | 86,626 | 879.95M |
| 359 | AVNS | Avanos Medical, Inc. | 1.17B | -0.18% | 309,983 | 715.90M |
| 360 | AHG | Akso Health Group | 1.16B | -6.89% | 4,149 | 14.84M |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.15B | -4.93% | 263,898 | - |
| 362 | OPK | OPKO Health, Inc. | 1.14B | -0.33% | 2,000,970 | 581.12M |
| 363 | DRTS | Alpha Tau Medical Ltd. | 1.13B | 11.41% | 2,219,639 | - |
| 364 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 6.50% | 1,659,435 | - |
| 365 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | -1.14% | 622,652 | - |
| 366 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.20% | 3,138,542 | 71.80M |
| 367 | OLMA | Olema Pharmaceuticals, Inc. | 1.09B | 2.75% | 2,454,794 | - |
| 368 | AORT | Artivion, Inc. | 1.09B | 0.54% | 913,296 | 458.69M |
| 369 | BIOA | BioAge Labs, Inc. | 1.09B | -1.80% | 805,363 | 10.32M |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | -1.70% | 661,541 | 1.03B |
| 371 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | -9.47% | 5,170,175 | 69.64M |
| 372 | CRON | Cronos Group Inc. | 1.06B | -2.63% | 1,321,392 | 159.54M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.05B | 0.39% | 192,300 | 787.69M |
| 374 | SANA | Sana Biotechnology, Inc. | 1.04B | 0.87% | 2,348,214 | - |
| 375 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | -4.86% | 1,145,640 | 1.03B |
| 376 | CERT | Certara, Inc. | 1.02B | 2.75% | 5,107,486 | 419.75M |
| 377 | EVO | Evotec SE | 1.01B | -0.36% | 25,842 | 859.03M |
| 378 | VOR | Vor Biopharma Inc. | 998.65M | -0.91% | 1,377,916 | - |
| 379 | PCRX | Pacira BioSciences, Inc. | 998.26M | 1.12% | 589,968 | 734.86M |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 989.55M | -1.65% | 443,182 | 86.93M |
| 381 | CNMD | CONMED Corporation | 987.58M | -4.68% | 460,114 | 1.37B |
| 382 | SLDB | Solid Biosciences Inc. | 982.53M | 5.39% | 2,366,613 | - |
| 383 | GDRX | GoodRx Holdings, Inc. | 978.77M | 1.40% | 976,948 | 787.89M |
| 384 | KURA | Kura Oncology, Inc. | 974.74M | 0.09% | 1,526,520 | 71.64M |
| 385 | AVTX | Avalo Therapeutics, Inc. | 971.41M | -4.20% | 2,399,780 | 59.00K |
| 386 | DBVT | DBV Technologies S.A. | 967.91M | 1.19% | 223,486 | 5.74M |
| 387 | AVR | Anteris Technologies Global Corp. | 958.82M | 0.72% | 1,744,968 | 1.85M |
| 388 | ABUS | Arbutus Biopharma Corporation | 948.18M | 2.56% | 3,344,412 | 191.45M |
| 389 | PHAR | Pharming Group N.V. | 947.75M | 2.39% | 6,746 | 369.49M |
| 390 | JANX | Janux Therapeutics, Inc. | 937.33M | 0.29% | 1,212,518 | 13.73M |
| 391 | ANNX | Annexon, Inc. | 937.18M | 2.69% | 3,631,711 | - |
| 392 | LBRX | LB Pharmaceuticals Inc | 930.84M | -0.55% | 326,527 | - |
| 393 | REPL | Replimune Group, Inc. | 928.43M | -1.25% | 4,293,675 | - |
| 394 | ANRO | Alto Neuroscience, Inc. | 927.88M | -5.81% | 424,076 | - |
| 395 | INMD | InMode Ltd. | 927.26M | -0.71% | 834,821 | 374.64M |
| 396 | DSGN | Design Therapeutics, Inc. | 902.50M | 1.47% | 1,192,669 | - |
| 397 | AMPH | Amphastar Pharmaceuticals, Inc. | 890.68M | -2.46% | 400,005 | 720.53M |
| 398 | ODTX | Odyssey Therapeutics, Inc. | 889.81M | -1.61% | 449,745 | 1.06M |
| 399 | TBPH | Theravance Biopharma, Inc. | 876.40M | -0.35% | 1,999,816 | 109.78M |
| 400 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 2,190,999 | 238.37M |
| 401 | IVA | Inventiva S.A. | 869.21M | 6.20% | 2,095,579 | 7.94M |
| 402 | PHAT | Phathom Pharmaceuticals, Inc. | 862.61M | -0.09% | 665,601 | 204.89M |
| 403 | ZVRA | Zevra Therapeutics, Inc. | 847.71M | 2.36% | 1,482,582 | 122.29M |
| 404 | GMRS | GMR Solutions Inc. | 838.26M | 5.43% | 1,209,124 | 5.83B |
| 405 | OCS | Oculis Holding AG | 836.98M | 5.88% | 632,815 | 1.40M |
| 406 | GERN | Geron Corporation | 817.94M | -1.92% | 12,331,230 | 196.12M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 817.47M | 0.40% | 5,864,366 | 35.54M |
| 408 | ESPR | Esperion Therapeutics, Inc. | 814.77M | 0.48% | 4,446,406 | 418.24M |
| 409 | SSII | SS Innovations International, Inc. | 800.53M | 13.31% | 245,237 | 48.47M |
| 410 | SPRY | ARS Pharmaceuticals, Inc. | 796.41M | -6.31% | 1,312,513 | 98.99M |
| 411 | HSTM | HealthStream, Inc. | 795.53M | 0.37% | 186,745 | 311.78M |
| 412 | BVS | Bioventus Inc. | 789.40M | -3.37% | 728,213 | 576.30M |
| 413 | AURA | Aura Biosciences, Inc. | 783.68M | 3.27% | 1,260,779 | - |
| 414 | SLBT | SL Science Holding Limited | 767.72M | 39.71% | 840,480 | - |
| 415 | CADL | Candel Therapeutics, Inc. | 755.42M | -0.48% | 2,926,457 | - |
| 416 | CLYM | Climb Bio, Inc. | 747.82M | -2.25% | 1,566,237 | - |
| 417 | SGP | SpyGlass Pharma, Inc. | 746.23M | 3.09% | 81,928 | - |
| 418 | TENX | Tenax Therapeutics, Inc. | 743.39M | 7.78% | 1,310,028 | - |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 739.52M | 5.48% | 2,986,650 | 8.37M |
| 420 | CBLL | CeriBell, Inc. | 737.23M | -2.66% | 505,079 | 95.07M |
| 421 | IMMX | Immix Biopharma, Inc. | 733.26M | -1.81% | 2,387,623 | - |
| 422 | RLMD | Relmada Therapeutics, Inc. | 726.89M | -0.72% | 2,320,329 | - |
| 423 | CSTL | Castle Biosciences, Inc. | 723.37M | -1.93% | 336,692 | 339.92M |
| 424 | SIBN | SI-BONE, Inc. | 722.89M | -3.44% | 1,638,028 | 206.22M |
| 425 | RIGL | Rigel Pharmaceuticals, Inc. | 722.51M | 0.03% | 337,018 | 299.77M |
| 426 | ALLO | Allogene Therapeutics, Inc. | 716.20M | -6.53% | 17,891,992 | 22.00K |
| 427 | EIKN | Eikon Therapeutics, Inc. | 707.05M | 2.51% | 350,545 | - |
| 428 | TRAX | First Tracks Biotherapeutics, Inc. | 703.08M | 18.46% | 879,732 | - |
| 429 | BBNX | Beta Bionics, Inc. | 699.84M | -7.62% | 715,466 | 110.24M |
| 430 | FDMT | 4D Molecular Therapeutics, Inc. | 696.06M | 3.38% | 1,296,269 | 88.24M |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 694.67M | -1.86% | 2,583,806 | 361.51M |
| 432 | OMER | Omeros Corporation | 689.01M | -3.94% | 1,944,760 | 9.89M |
| 433 | TCMD | Tactile Systems Technology, Inc. | 671.27M | -1.68% | 102,399 | 343.52M |
| 434 | DRUG | Bright Minds Biosciences Inc. | 671.06M | 2.99% | 258,161 | - |
| 435 | ACHV | Achieve Life Sciences, Inc. | 670.88M | 4.90% | 2,458,768 | - |
| 436 | PRME | Prime Medicine, Inc. | 665.58M | -0.94% | 2,669,629 | 4.03M |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 646.71M | -3.04% | 1,043,508 | 151.40M |
| 438 | TECX | Tectonic Therapeutic, Inc. | 645.89M | 3.45% | 191,478 | - |
| 439 | FTH | Faeth Therapeutics, Inc. | 644.47M | 7.67% | 123,372 | - |
| 440 | AGMB | AgomAb Therapeutics NV | 644.16M | -26.60% | 259,322 | - |
| 441 | PHR | Phreesia, Inc. | 636.66M | 0.10% | 1,031,504 | 495.59M |
| 442 | RGNX | REGENXBIO Inc. | 620.89M | 1.52% | 1,611,106 | 87.82M |
| 443 | BWAY | BrainsWay Ltd. | 618.99M | 2.11% | 65,547 | 56.22M |
| 444 | MNPR | Monopar Therapeutics Inc. | 617.16M | -2.57% | 99,923 | - |
| 445 | CRMD | CorMedix Inc. | 616.63M | 2.88% | 1,358,869 | 400.05M |
| 446 | PROK | ProKidney Corp. | 614.69M | 7.67% | 3,578,032 | 889.00K |
| 447 | CTNM | Contineum Therapeutics, Inc. | 613.14M | 9.33% | 661,523 | - |
| 448 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 610.02M | -0.59% | 397,457 | - |
| 449 | EVH | Evolent Health, Inc. | 607.96M | -6.33% | 2,509,296 | 1.89B |
| 450 | GYRE | Gyre Therapeutics, Inc. | 602.14M | 2.17% | 47,083 | 117.05M |
| 451 | CBIO | Crescent Biopharma, Inc. | 597.79M | -0.06% | 266,996 | 11.88M |
| 452 | NNNN | Anbio Biotechnology | 590.34M | -0.74% | 46,832 | 8.65M |
| 453 | ALT | Altimmune, Inc. | 590.23M | 3.23% | 4,327,774 | 36.00K |
| 454 | CTEV | Claritev Corporation | 588.32M | 2.04% | 179,921 | 978.76M |
| 455 | CERS | Cerus Corporation | 585.08M | -2.34% | 2,173,099 | 216.56M |
| 456 | FLGT | Fulgent Genetics, Inc. | 582.64M | -0.07% | 251,701 | 320.35M |
| 457 | MDXG | MiMedx Group, Inc. | 573.44M | -1.53% | 1,187,823 | 389.42M |
| 458 | CTKB | Cytek Biosciences, Inc. | 572.10M | 2.07% | 1,178,941 | 204.17M |
| 459 | ZURA | Zura Bio Limited | 560.96M | 4.88% | 2,584,963 | - |
| 460 | RZLT | Rezolute, Inc. | 551.58M | 3.53% | 2,285,342 | - |
| 461 | STRO | Sutro Biopharma, Inc. | 550.30M | -0.42% | 344,480 | 99.61M |
| 462 | ASMB | Assembly Biosciences, Inc. | 548.05M | 2.58% | 249,379 | 71.10M |
| 463 | TOI | The Oncology Institute, Inc. | 543.41M | -2.95% | 2,159,129 | 545.76M |
| 464 | NPCE | NeuroPace, Inc. | 543.11M | -3.63% | 162,605 | 99.53M |
| 465 | ANGO | AngioDynamics, Inc. | 541.03M | -1.67% | 164,658 | 313.73M |
| 466 | KYTX | Kyverna Therapeutics, Inc. | 540.77M | 1.31% | 1,235,411 | - |
| 467 | MYGN | Myriad Genetics, Inc. | 539.30M | -2.39% | 1,597,653 | 829.00M |
| 468 | CLPT | ClearPoint Neuro, Inc. | 535.91M | -8.03% | 1,020,279 | 40.61M |
| 469 | ARVN | Arvinas, Inc. | 535.53M | 0.12% | 518,371 | 89.40M |
| 470 | TLRY | Tilray Brands, Inc. | 534.98M | -2.71% | 3,713,755 | 858.28M |
| 471 | STTK | Shattuck Labs, Inc. | 532.55M | 1.39% | 1,886,880 | 1.00M |
| 472 | XOMA | XOMA Royalty Corporation | 532.37M | 0.71% | 199,998 | 48.56M |
| 473 | PRLD | Prelude Therapeutics Incorporated | 527.62M | 7.91% | 824,889 | 16.72M |
| 474 | FBRX | Forte Biosciences, Inc. | 525.73M | 0.91% | 376,512 | - |
| 475 | AQST | Aquestive Therapeutics, Inc. | 523.13M | 0.24% | 1,486,000 | 50.27M |
| 476 | PACB | Pacific Biosciences of California, Inc. | 520.26M | -3.18% | 6,879,438 | 160.03M |
| 477 | OCGN | Ocugen, Inc. | 519.63M | -8.08% | 11,293,830 | 4.47M |
| 478 | CCCC | C4 Therapeutics, Inc. | 514.69M | 7.01% | 6,610,800 | 34.86M |
| 479 | SLN | Silence Therapeutics plc | 514.38M | 0.93% | 556,735 | 839.00K |
| 480 | PRTA | Prothena Corporation plc | 512.28M | -1.86% | 339,623 | 57.94M |
| 481 | CABA | Cabaletta Bio, Inc. | 508.73M | 0.32% | 4,562,732 | - |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 483 | OVID | Ovid Therapeutics Inc. | 501.13M | -1.29% | 2,967,244 | 7.12M |
| 484 | EDIT | Editas Medicine, Inc. | 497.22M | 1.25% | 1,778,538 | 38.69M |
| 485 | NGNE | Neurogene Inc. | 496.02M | -2.76% | 142,889 | 925.00K |
| 486 | KIDS | OrthoPediatrics Corp. | 493.28M | -4.36% | 242,487 | 243.30M |
| 487 | VALN | Valneva SE | 488.58M | 0.19% | 32,114 | 180.25M |
| 488 | NVCT | Nuvectis Pharma, Inc. | 486.74M | -35.68% | 3,130,434 | - |
| 489 | NRC | NRC Health | 484.09M | -0.74% | 116,765 | 138.64M |
| 490 | SOPH | SOPHiA GENETICS SA | 484.08M | -3.51% | 743,052 | 81.18M |
| 491 | EVMN | Evommune, Inc. | 479.76M | -11.50% | 1,737,021 | 10.00M |
| 492 | SGMT | Sagimet Biosciences Inc. | 477.65M | -0.71% | 900,782 | - |
| 493 | WEAV | Weave Communications, Inc. | 476.20M | -2.37% | 964,884 | 248.72M |
| 494 | ARTV | Artiva Biotherapeutics, Inc. | 469.85M | 0.94% | 487,328 | 251.00K |
| 495 | VTVT | vTv Therapeutics Inc. | 467.84M | 3.94% | 87,335 | 36.84M |
| 496 | ANL | Adlai Nortye Ltd. | 462.60M | 1.36% | 176,838 | 5.00M |
| 497 | EOLS | Evolus, Inc. | 457.03M | -2.66% | 595,532 | 301.79M |
| 498 | SRTA | Strata Critical Medical, Inc. | 455.13M | 1.54% | 2,794,198 | 228.58M |
| 499 | BNTC | Benitec Biopharma Inc. | 453.99M | 4.06% | 48,791 | - |
| 500 | CYH | Community Health Systems, Inc. | 453.09M | -1.33% | 1,441,804 | 12.29B |